Your browser doesn't support javascript.
loading
Efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) on anemia in non-dialysis-dependent chronic kidney disease (NDD-CKD): a systematic review and meta-analysis.
Zhang, Siliang; Guo, Jing; Xie, Shuqin; Chen, Jianwei; Yu, Shenrun; Yu, Yuan.
Afiliação
  • Zhang S; Department of Nephrology, The Second Affiliated Hospital, Chongqing Medical University, Lingjiang Road, Yuzhong District, Chongqing, 400010, China.
  • Guo J; Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing, 400030, China.
  • Xie S; Department of Nephrology, The Second Affiliated Hospital, Chongqing Medical University, Lingjiang Road, Yuzhong District, Chongqing, 400010, China.
  • Chen J; Department of Nephrology, The Second Affiliated Hospital, Chongqing Medical University, Lingjiang Road, Yuzhong District, Chongqing, 400010, China.
  • Yu S; Center of Urology and Nephrology, Yongchuan People's Hospital of Chongqing, Chongqing, 402160, China.
  • Yu Y; Department of Nephrology, The Second Affiliated Hospital, Chongqing Medical University, Lingjiang Road, Yuzhong District, Chongqing, 400010, China. yuyuan@cqmu.edu.cn.
Int Urol Nephrol ; 53(6): 1139-1147, 2021 Jun.
Article em En | MEDLINE | ID: mdl-33026571

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prolina Dioxigenases do Fator Induzível por Hipóxia / Anemia Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prolina Dioxigenases do Fator Induzível por Hipóxia / Anemia Idioma: En Ano de publicação: 2021 Tipo de documento: Article